OSCAR LORA: Open Payments
NPI 1720756596 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 7 companies in 2025. Trend: 2023 $217 · 2024 $150 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| ACCORD HEALTHCARE, INC. | 1 | $14 |
Products named: CABOMETYX, WAYRILZ, PYRUKYND, MONJUVI, SCEMBLIX, Phesgo, Camcevi.
Industry payments across TX — which companies pay providers there.
